2024, FDA and Health Services Administration - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2024

FDA

Health Services Administration

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps

Bill of Health

NOVEMBER 15, 2023

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.

Governance

Governance Public Health Telemedicine COVID-19

Medical Device Cybersecurity Provisions Included in Omnibus Appropriations Bill

HIPAA Journal

DECEMBER 22, 2022

The bill will also provide funding for essential behavioral health programs and several provisions that will help to increase the healthcare workforce. Funding for the Centers for Medicare and Medicaid Services will increase by $100 million, the National Institutes of Health will receive an additional $2.5

FDA

FDA COVID-19 Governance Medicaid

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

JANUARY 25, 2023

Telehealth Section 4113 of the Act extends certain Medicare telehealth flexibilities that were allowed during the COVID-19 PHE for two years, through 2024. HHS is directed to submit to Congressional committees the result of findings in an interim report in October 2024 and a final report in August 2026.

Medicaid

Medicaid Medicaid Medicare Medicare

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps

Medical Device Cybersecurity Provisions Included in Omnibus Appropriations Bill

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

Webinars

Stay Connected